References

Buprenorphine versus methadone for opioid use disorder in pregnancy

10.1056/nejmoa2203318 · External reference

Unresolved reference

External reference

Neonatal abstinence syndrome after methadone or buprenorphine exposure

10.1056/nejmoa1005359 · External reference

Birth and neonatal outcomes following opioid use in pregnancy: a Danish population-based study

External reference

Reviewing the impact of maternal opioid use disorder on fetal development and long-term pediatric health outcomes

External reference

Risk factors for preterm birth among gravid individuals receiving buprenorphine for opioid use disorder

10.1016/j.ajogmf.2022.100582 · External reference

First trimester use of buprenorphine or methadone and the risk of congenital malformations

10.1001/jamainternmed.2023.6986 · External reference

Infant mortality associated with prenatal opioid exposure

10.1001/jamapediatrics.2020.6364 · External reference

Educational disabilities among children born with neonatal abstinence syndrome

10.1542/peds.2018-0562 · External reference

Neonatal abstinence syndrome and high school performance

10.1542/peds.2016-2651 · External reference

Adverse neurodevelopmental outcome of infants exposed to opiate in-utero

10.1016/j.earlhumdev.2007.01.013 · External reference

Association of maternal buprenorphine or methadone dose with fetal growth indices and neonatal abstinence syndrome

External reference

Neonatal head circumference in newborns with neonatal abstinence syndrome

10.1542/peds.2018-0541 · External reference

Volumetric cerebral characteristics of children exposed to opiates and other substances in utero

10.1016/j.neuroimage.2007.03.070 · External reference

Opioids affect the fetal brain: reframing the detoxification debate

10.1016/j.ajog.2019.07.022 · External reference

Do maternal opioids reduce neonatal regional brain volumes? A pilot study

10.1038/jp.2014.111 · External reference

Implications of perinatal buprenorphine exposure on infant head circumference at birth

10.1080/14767058.2019.1599352 · External reference

Impact of opioid maintenance treatment during pregnancy on neonatal birth weight and head circumference

10.3233/npm-200645 · External reference

Head circumference and intelligence, schooling, employment, and income: a systematic review

10.1186/s12887-024-05159-2 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Practical significance: a concept whose time has come

10.1177/0013164496056005002 · External reference

MRI findings in third-trimester opioid-exposed fetuses, with focus on brain measurements: a prospective multicenter case-control study

10.2214/ajr.22.28357 · External reference

Brain morphology in school-aged children with prenatal opioid exposure: a structural MRI study

10.1016/j.earlhumdev.2017.01.009 · External reference

Cognitive and behavioral impact on children exposed to opioids during pregnancy

10.1542/peds.2019-0514 · External reference

High prevalence of buprenorphine in prenatal drug screens in an Appalachian city

10.14423/smj.0000000000001072 · External reference

Outpatient tapering of buprenorphine in opioid use disorder pregnancies may improve neonatal outcomes

10.1038/s41372-025-02211-6 · External reference

Unresolved reference

External reference

Assessing neonatal opioid withdrawal syndrome severity as a function of maternal buprenorphine dose and umbilical cord tissue concentrations

10.1177/10600280221134643 · External reference

Weaning buprenorphine in pregnant patients#

10.1080/14767058.2024.2337711 · External reference

Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?

10.1111/ajad.13652 · External reference